| DIALOG/PROGRESS NOTE TEXT |
A single dose of Tetanus Toxoid, Reduced Diphtheria Toxoid and
Adults who have or who anticipate having close contact with an infant
aged <12 months (e.g., parents, grandparents, child-care providers, and
health care providers [HCPs]) should receive a single dose of Tdap as
soon as feasible if they have not previously received Tdap or if
immunization status is unknown. Ideally, these adults should receive Tdap
at least 2 weeks before beginning close contact with the infant.
Patients who are health-care personnel (HCP) who work in hospitals or
ambulatory care settings and have direct patient contact should receive a
single dose of Tdap as soon as feasible if they have not previously
Acellular Pertussis vaccine (Tdap) should be given regardless of when the
received Tdap.
If a vaccine other than Tdap is also indicated, it should be administered
during the same visit (i.e., simultaneous vaccination). Each vaccine
should be administered using a separate syringe at a different anatomic
site.
last Tetanus containing product was received in adults who have not
previously received Tdap. In addition, pregnant women should receive an
additional dose during each pregnancy.
When to Administer:
Each pregnancy with Tdap (preferably during the third trimester).
|
